4.7 Article

Easy-to-Use Osmosis-Based Microfluidic Chip for Protein Crystallization: Application to a Monoclonal Antibody

Journal

CRYSTAL GROWTH & DESIGN
Volume 21, Issue 6, Pages 3469-3476

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/acs.cgd.1c00248

Keywords

-

Funding

  1. European Union's Horizon 2020, Future and Emerging Technologies program (FET-OPEN), AMECRYS project [712965]

Ask authors/readers for more resources

The developed disposable microfluidic chip mimics the vapor diffusion method for exploring protein crystallization conditions and allows for quantitative information extraction on the crystallization process. Experiments conducted on a therapeutic protein show the estimation of solubility, width of the metastable zone, and the ability to perform crystallization/dissolution cycles for selective dissolution and crystal size increase.
We developed a disposable microfluidic chip which mimics the vapor diffusion method for exploring protein crystallization conditions but at the nanoliter scale. This device exploits the permeation of water through a thin poly(dimethylsiloxane) (PDMS) layer separating droplets stored in the chip and containing a mixture of proteins and precipitants from an open microfluidic reservoir. The water chemical activity fixed by the reservoir makes it possible to modify the volume of the droplets in a controlled way (reduction or increase). Because PDMS is only permeable to water, the imposed water activity therefore increases or decreases the concentration of the solutes present in the droplet and consequently the supersaturation of the solution. The specificity of our approach, in addition to the low volumes ensuring controlled mass transport conditions, is that the concentration of all the solutes is known at any time, thus allowing the extraction of quantitative information on the crystallization process. We exploit these chips on a protein of therapeutic interest: the full-length monoclonal antibody anti-CD20. Our experiments allow us in particular to estimate both the solubility of this protein and the width of the metastable zone with Na2SO4 and PEG400 as crystallizing agents. We also show that the fine-tuning of the permeation rate makes it possible to perform crystallization/dissolution cycles to selectively dissolve small crystals and increase the mean size of the remaining anti-CD20 crystals.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available